Mutations clustering around the ATP‐binding pocket of the tyrosine kinase domain lead to constituent, ligand‐independent activation of EGFR, which results in inappropriate activation of the antiapoptotic Ras signaling pathway and abnormal proliferation of cancer cells.92, 93. The gene discussed is EGFR; the disease is cancer.